Recent Advances in Supramolecular-Macrocycle-Based Nanomaterials in Cancer Treatment

Zheng Pan1,2, Xinzhi Zhao1,2, Qiushi Li1,2

  • 1Key Laboratory of Functional Polymer Materials (Ministry of Education), College of Chemistry, Nankai University, Tianjin 300071, China.

Insights

Supramolecular chemistry utilizes host-guest interactions for advanced cancer therapy. This review explores macrocyclic molecules and stimulus-responsive systems for targeted drug delivery, improving cancer treatment outcomes.

Area of Science:

  • Biomedical applications
  • Supramolecular chemistry
  • Nanomaterials

Background:

  • Cancer remains a significant global health challenge.
  • Current cancer therapies like chemotherapy have limitations.
  • Supramolecular chemistry offers novel approaches for enhanced drug delivery.

Purpose of the Study:

  • To review macrocyclic molecules and stimulus-responsive strategies for controlled drug release.
  • To discuss the application of supramolecular-macrocycle-based nanomaterials in cancer therapy.
  • To highlight existing challenges and future prospects in this field.

Main Methods:

  • Review of major macrocyclic molecules.
  • Analysis of stimulus-response strategies for controlled release.
  • Compilation of applications in cancer therapy.

Main Results:

  • Supramolecular chemistry provides tools for targeted drug delivery.
  • Stimulus-responsive systems enable precise therapeutic agent release.
  • Macrocycle-based nanomaterials show promise in cancer treatment.

Conclusions:

  • Supramolecular chemistry is a promising avenue for improving cancer therapeutics.
  • Controlled release systems are key to enhancing treatment efficacy.
  • Further research is needed to overcome current challenges and realize the full potential of these nanomaterials.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K